Cost-Effectiveness and Budget Impact Analysis of Apatinib for Advanced Metastatic Gastric Cancer from the Perspective of Health Insurance System

<div>A tornado diagram representing the one-way sensitivity analysis of apatinib with 3 + X PAP versus the control strategy. OS: overall survival; PFS: progression-free survival; HR: hazard ratio.</div>

Gastroenterology Research and Practice

fig3

Figure 3

Figure 3: Cost-Effectiveness and Budget Impact Analysis of Apatinib for Advanced Metastatic Gastric Cancer from the Perspective of Health Insurance System 

Figure 3 | Cost-Effectiveness and Budget Impact Analysis of Apatinib for Advanced Metastatic Gastric Cancer from the Perspective of Health Insurance System 